Princeton Global Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Princeton Global Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-29	Closed	-$1K	–	549
2022 Q3	$1K	Hold	29	–	–	﹤0.01%	512
2022 Q2	$1K	Hold	29	–	–	﹤0.01%	523
2022 Q1	$1K	Hold	29	–	–	﹤0.01%	549
2021 Q4	$1K	Hold	29	–	–	﹤0.01%	496
2021 Q3	$1K	Hold	29	–	–	﹤0.01%	487
2021 Q2	$2K	Hold	29	–	–	﹤0.01%	499
2021 Q1	$1K	Hold	29	–	–	﹤0.01%	464
2020 Q4	$1K	Hold	29	–	–	﹤0.01%	458
2020 Q3	$1K	Hold	29	–	–	﹤0.01%	424
2020 Q2	$1K	Hold	29	–	–	﹤0.01%	487
2020 Q1	$1K	Hold	29	–	–	﹤0.01%	465
2019 Q4	$1	Hold	29	–	–	﹤0.01%	482
2019 Q3	$1K	Buy	+29	New	+$1.2K	﹤0.01%	339

Other funds holding AGIO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Princeton Global Asset Management's AGIO Position: Q4 2022 in Review

Princeton Global Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2022, closing a stake of 29 shares — an estimated $1K sold.

Princeton Global Asset Management first reported a position in AGIO in Q3 2019 and held it in 13 quarters. The position peaked at $2K in Q2 2021. 159 funds tracked by Wall St. Rank hold AGIO as of Q4 2022.

Princeton Global Asset Management reported no remaining Agios Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Princeton Global Asset Management sold 29 Agios Pharmaceuticals shares in Q4 2022, an estimated $1K.
Princeton Global Asset Management first reported a position in Agios Pharmaceuticals in Q3 2019 and held it in 13 quarters.
Princeton Global Asset Management's Agios Pharmaceuticals position peaked at $2K in Q2 2021.
159 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2022.

Based on Princeton Global Asset Management's 13F filing for Q4 2022, filed 6 Feb 2023.